News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Pulse Biosciences (PLSE) recently announced a $75 million at-the-market equity offering and reported wider second-quarter losses, impacting existing shareholders. Despite strong recent share price performance, with a 30-day return of 55.30% and a year-to-date return of 232.64%, the stock now trades above the latest …
Alset (NASDAQ:AEI) reported a quarterly loss of $0.14 per share, with negative returns on equity and net margin. Despite a 14.5% rise in share price to $1.34 on Friday, the stock remains significantly below its 52-week high, and analysts maintain a "Sell" rating. CEO …
ExlService Holdings (EXLS) has acquired iMerit, integrating its founder and CEO into EXL's executive team to enhance AI and data annotation capabilities. This acquisition strengthens EXL's position in data-centric services, particularly in regulated industries like insurance, aligning with its strategy to scale AI-driven services. …
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all. That's because, these stocks usually carry above-average risk …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Investor Relations - Philip TaylorCo-Chair of the Board and Chief Executive Officer - Paul LaVioletteChief Financial Officer - Jon SkinnerCo-Chair of the Board - Bob Duggan Need a …
ExlService Holdings, Inc.'s Executive Vice President, Vishal Chhibbar, reported selling 5,000 shares of common stock on August 11, 2026, at $35.10 per share. This transaction was not conducted under a Rule 10b5-1 trading plan. Following the sale, Chhibbar directly holds 6,452 shares of the …
Pulse Biosciences (NASDAQ:PLSE) stock reached a new 52-week high of $46.03, closing at $46.75, despite reporting weaker-than-expected quarterly results. Analyst sentiment is mixed, with a "Moderate Buy" consensus but an average price target below the current trading price. Institutional investors hold a significant 76.95% …
Pulse Biosciences Inc. (PLSE) stock hit an all-time high of $46.03, currently trading near its 52-week high of $45.90, despite a recent report of wider-than-expected Q2 2026 losses and lower revenue. The stock has seen a significant 163.78% one-year increase and 216% year-to-date, boosting …
FingerMotion, Inc. (NasdaqCM:FNGR) has agreed to acquire a 9.9% stake in Cedarcross International Technologies Inc. from Alset AI Ventures Inc. (TSXV:GPUS) for $0.48 million. The consideration involves the issuance of 1.7 million shares by FingerMotion, Inc., and Alset AI Ventures Inc. is expected to …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Alsea now carries an updated Fair Value estimate of MX$60.99, down from MX$67.25, which reflects a roughly 9% reset in the price target …
EXL (NASDAQ: EXLS) has been recognized as a Leader for the fourth consecutive year in the ISG Provider Lens® Insurance Services 2026 reports for both Property & Casualty and Life & Retirement services. ISG highlighted EXL's strong combination of insurance domain expertise, data, analytics, …
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amended Schedule 13G, reporting a beneficial ownership of 6,812,609 shares, representing 4.46% of ExlService Holdings, Inc.'s common stock. This filing indicates that all voting and dispositive authority is shared between the …
Handelsbanken Fonder AB significantly reduced its stake in ExlService Holdings, Inc. (NASDAQ:EXLS) by selling over 1 million shares, now owning 1.08% of the company. Other institutional investors showed mixed activity, with some increasing and others initiating new positions. Insider trading also occurred, with executives …
Pulse Biosciences, Inc. (PLSE) is developing next-generation nsPFA technology for AFib treatment, demonstrating high efficacy and efficiency. The company's leadership, strong clinical data, competitive position, and partnership strategy are expected to drive broad clinical adoption. This information is based on an audio transcript from …
ExlService Holdings (EXLS) recently raised its 2026 revenue outlook and acquired iMerit, leading to a 28.46% share price jump in one month. While a detailed narrative suggests the stock is 19.4% undervalued with a fair value of $43.50, driven by AI-led growth, its P/E …
This article analyzes the historical performance of an investment in Alset AI Ventures Inc (ALSCF), detailing how a $1,000 investment would have fared over different periods. It shows significant declines for investments made five years ago and since 2016, along with the company's annual …
Pulse Biosciences (PLSE) is under scrutiny after reporting a wider quarterly net loss and a US$75 million equity offering, despite its NANOPULSE-AF Study reaching its enrollment midpoint. The stock has seen significant gains, but analysts are concerned about its valuation, with a fair value …
Wall Street Zen has downgraded Pulse Biosciences (NASDAQ:PLSE) from "hold" to "sell," despite a broader analyst consensus of "Moderate Buy" with an average price target of $32.33. The company's stock opened at $42.41, up 10.9%, but it missed analyst expectations for its last quarterly …
This article provides an earnings forecast for Leishen Energy Holding Co Ltd (LSE), detailing its future EPS and revenue growth estimates. It includes current stock information, market capitalization, P/E ratio, and lists peer companies with their analyst ratings. The forecast section covers EPS, Revenue, …
Pulse Biosciences (NASDAQ:PLSE) experienced a 15.7% surge in its stock price, reaching approximately $44.26, despite a 51% drop in trading volume. The company holds a "Moderate Buy" consensus from analysts, though its average price target of $32.33 is below the current share price. This …
This article provides current stock information for Australian Oilseeds Holdings Ltd (COOT), showing a recent increase of +2.94% to 0.407 USD. It indicates that more news, earnings, and analyst ratings for COOT are expected soon. The page serves as a hub for following developments …
PULSE BIOSCIENCES, INC. reported product revenue of $434K and a net loss of ($24.66M) or diluted loss per share of ($0.36) for the current quarter of 2026. This compares to no product revenue and a ($19.17M) net loss or ($0.28) per share in the …
This article provides a technical analysis of Alset Inc (AEI), detailing its current price momentum score, support and resistance levels, and indicator readings. It also includes an analysis of various technical indicators like MACD, RSI, and moving averages, offering insights into potential buy, sell, …
The technical analysis for Alset Inc (AEI) shows a Neutral sentiment, with an aggregated analysis indicating 5 buy signals and 6 sell signals from 11 technical indicators. The stock is currently trading at $1.18, below its 60-day ($1.343) and 200-day ($2.08) moving averages, suggesting …
This article announces the filing of a Form 8K by Pulse Biosciences Inc. on August 6th. The brief notice from Investing.com indicates that the information pertains to the company's financial activities or significant events as required by the SEC.
Pulse Biosciences announced its business updates and financial results for the second quarter ended June 30, 2026, highlighting significant progress in its cardiac catheter program. The company surpassed the halfway point of enrollment in its U.S. pivotal NANOPULSE-AF study, raising $46.8 million in net …
The California State Teachers Retirement System increased its stake in ExlService Holdings, Inc. (NASDAQ:EXLS) by 24% in the first quarter, now owning 189,097 shares valued at $5.8 million. Despite this institutional accumulation, company insiders have sold approximately $895,787 worth of shares over the past …
Pulse Biosciences (PLSE) reported a Q2 loss of $0.36 per share, missing the Zacks Consensus Estimate of a $0.31 loss and underperforming the previous year's loss of $0.28 per share. The company also missed revenue estimates, posting $0.43 million against a 38% higher Zacks …
Pulse Biosciences has entered into an equity distribution agreement with Mizuho Securities USA LLC, allowing it to offer and sell up to $75 million in common stock. Mizuho will act as the sales agent, receiving a commission of up to 3.0% on shares sold. …
Search by ticker symbol or company name and select a result to open its chart.